West Pharmaceutical Services Inc (WST)

Finanzdaten der West Pharmaceutical Services Inc-Aktie (WST)

Gewinn- und Verlustrechnung

Vierteljährlich

*Alle Zahlen in Millionen

Enddatum des Zeitraums	2024-03-31	2023-12-31	2023-09-30	2023-06-30	2023-03-31
Periodenlänge	3 Monate	3 Monate	3 Monate	3 Monate	3 Monate
Revenues	5.00% 695.40	732.00	747.40	753.80	716.60
Cost Of Revenue	2.51% 465.20	453.80	459.10	462.40	445.30
Gross Profit	17.25% 230.20	278.20	288.30	291.40	271.30
Operating Expenses	8.44% 107.40	117.30	111.00	108.90	116.00
Interest Income/Expense	33.33% 1.60	1.20	2.90	2.70	2.20
Benefits Costs and Expenses	0.74% 568.00	563.80	560.40	568.90	558.70
Costs And Expenses	0.74% 568.00	563.80	560.40	568.90	558.70
Operating Income/Loss	23.68% 122.80	160.90	177.30	182.50	155.30
Nonoperating Income/Loss	36.99% 4.60	7.30	9.70	2.40	2.60
Income/Loss Before Equity Method Investments	24.26% 127.40	168.20	187.00	184.90	157.90
Income/Loss From Equity Method Investments	30.30% 4.30	3.30	3.70	5.00	5.70
Income/Loss From Continuing Operations Before Tax	24.26% 127.40	168.20	187.00	184.90	157.90
Income Tax Expense/Benefit	52.46% 16.40	34.50	29.40	34.80	23.60
Income/Loss From Continuing Operations After Tax	16.98% 111.00	133.70	157.60	155.10	140.00
Net Income/Loss	15.84% 115.30	137.00	161.30	155.10	140.00
Preferred Stock Dividends And Other Adjustments	-	-	-	-	-
Attributable To Noncontrolling Interest	-	-	-	-	-
Basic Average Shares	73,600% 73.50	-0.10	74.30	74.30	74.50
Diluted Average Shares	37,250% 74.30	-0.20	75.30	75.40	75.70
Basic Earnings Per Share	15.14% 1.57	1.85	2.17	2.08	1.88
Diluted Earnings Per Share	15.30% 1.55	1.83	2.14	2.06	1.85
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic	-	-	-	-	-